发明名称 |
TREATMENT OF HODGKIN'S LYMPHOMA USING AN ANTI-PD-1 ANTIBODY |
摘要 |
This disclosure provides methods for treating Hodgkin's lymphoma in a subject comprising administering to the subject an anti-Programmed Death-1 (PD-1) antibody. In some embodiments, this invention relates to methods for treating Hodgkin's lymphoma in a subject comprising administering to the subject a combination of an anti-cancer agent which is an anti-Programmed Death-1 (PD-1) antibody and another anti-cancer agent such as an anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody. |
申请公布号 |
US2016347836(A1) |
申请公布日期 |
2016.12.01 |
申请号 |
US201615164960 |
申请日期 |
2016.05.26 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
Grosso Joseph |
分类号 |
C07K16/28;C12Q1/68;G01N33/574;A61K39/395;A61K45/06 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for treating a subject afflicted with a Hodgkin's lymphoma comprising administering to the subject a therapeutically effective amount of an antibody or an antigen-binding portion thereof that binds specifically to a Programmed Death-1 receptor (PD-1). |
地址 |
Princeton NJ US |